Christopher Peterson, DPM
Podiatrist · Miami, FLNPI 1871525170
Payments from drug & device makers
Across 28 payments — averaging $54.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$323
- Amgen$185
- Abbott$130
- Amarin Pharma, Inc.$128
- Xeris Pharmaceuticals, Inc.$128
- AstraZeneca$125
- plus $508 from 9 others
What the payments were for
- Food & beverage$1,527100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $323 |
| Amgen(2 entities) | 2 | $185 |
| Abbott | 2 | $130 |
| Amarin Pharma, Inc. | 1 | $128 |
| Xeris Pharmaceuticals, Inc. | 2 | $128 |
| AstraZeneca | 1 | $125 |
| Mannkind Corporation | 1 | $125 |
| Esperion Therapeutics, Inc. | 1 | $118 |
| Intuity Medical Inc | 1 | $90 |
| Medtronic | 1 | $76 |
| IBSA Pharma Inc. | 2 | $30 |
| Novo Nordisk | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| BD | 1 | $14 |
| Phadia US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,527 in reported general payments places this provider in the 60th percentile of 588 podiatrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 366 | $9,295 |
| MupirocinMupirocin Calcium | 27 | $5,395 |
| Ciclopirox | 160 | $2,647 |
| Ketoconazole | 122 | $1,914 |
| Doxycycline Monohydrate | 19 | $1,110 |
| Mupirocin | 89 | $1,104 |
| Terbinafine Hcl | 110 | $1,071 |
| Triamcinolone Acetonide | 28 | $465 |
| Gabapentin | 25 | $438 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $434 |
| Diclofenac Sodium | 20 | $232 |
| Ibuprofen | 14 | $139 |
| Meloxicam | 54 | $108 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Miami
- John TorregrosaMiami$64K
- Daniel StewartMiami$22K
- Juan Diaz-HernandezMiami$10K
- James CottomSarasota$1.9M
- Desmond BellJacksonville$365K
- Caroline KiserFleming Island$206K
- Adam PerlerLargo$160K
- Jeffrey KarrLakeland$101K
- Marie WilliamsAventura$96K
- Todd BrennanTampa$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.